Back to mobile site

Goldman Sachs Reiterates Buy Rating on Merck (MRK)

June 3, 2025 7:17 AM EDT Send to a Friend
Goldman Sachs analyst Asad Haider reiterated a Buy rating and $99.00 price target on Merck (NYSE: MRK).The analyst comments "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login